Related Experiment Video
Updated: May 17, 2026
03:06
Combination of High Ligation and Intraoperative Embolization Using Polidocanol for Treatment of Varicoceles
Published on: December 22, 2023
Sclerotherapy for hydrocele revisited: a prospective randomised study
M S Agrawal1, H Yadav, A Upadhyay
1Department of Surgery, S. N. Medical College, Agra, India.
The Indian Journal of Surgery
|November 8, 2012
Summary
Phenol sclerotherapy for hydrocele offers high cure rates comparable to surgery, with significantly less pain and shorter recovery. Polidocanol sclerotherapy showed lower efficacy and higher pain scores compared to phenol.
Area of Science:
- Urology
- Surgical Innovation
- Minimally Invasive Procedures
Background:
- Hydrocele, a common condition, traditionally treated with surgery.
- Sclerotherapy offers a less invasive alternative, but optimal agents require investigation.
Purpose of the Study:
- To compare the efficacy and safety of phenol and polidocanol sclerotherapy versus traditional surgical repair for vaginal hydroceles.
Main Methods:
- Prospective randomized trial involving 86 patients with unilateral primary vaginal hydroceles.
- Three groups: phenol sclerotherapy (5% phenol), polidocanol sclerotherapy (1% polidocanol), and surgical repair (Jaboulay's procedure).
- Outpatient procedures with statistical analysis via ANOVA.
Main Results:
- Phenol sclerotherapy achieved a 96.5% cure rate, comparable to surgery (100%) but superior to polidocanol (51.7%).
- Phenol group reported significantly lower pain scores and shorter hospital stays/work resumption times than surgery.
- Polidocanol group showed higher pain scores and less favorable outcomes than phenol and surgery.
Conclusions:
- 5% phenol sclerotherapy is a highly effective and safe treatment for hydrocele, matching surgical outcomes with reduced morbidity.
- Phenol is a superior sclerosant compared to polidocanol for hydrocele treatment.
- Sclerotherapy with phenol presents a viable, less invasive alternative to surgical hydrocelectomy.
